SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
VistaGen Therapeutics, Inc. And Wisconsin Alumni Research Foundation (WARF) Sign License Agreement for Human Embryonic Stem Cell Technology